written on 17.03.2014

Idenix files more patent infringement suits against Gilead

TAGS: ,

The lawsuits are alleging Gilead has infringed Idenix's recently-granted, co-owned European patent EP 1523489, which covers 2'-methyl-2'-fluoro nucleosides for treating the hepatitis C virus (HCV).